Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03825809 · ClinicalTrials.gov registry record · Phase 2

Nonopioid Analgesia After Labral Surgery

A Phase 2 study of Narcotic Use, sponsored by Henry Ford Health System.

Recruiting
Registry status
Phase 2
Development phase
100
Enrollment target
1
Study location

NCT03825809: Recruiting Phase 2 study of Narcotic Use, sponsored by Henry Ford Health System.

NCT03825809 is a Phase 2 study of Narcotic Use that is actively recruiting participants, run by Henry Ford Health System. The registered enrollment target is 100 participants, roughly in line with the 101-participant average among 3 other Narcotic Use trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03825809, a Phase 2 study of Narcotic Use, is actively recruiting participants, sponsored by Henry Ford Health System.

RECRUITING
Registry status
Phase 2
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen

Primary Outcome

Patients recorded pain levels 3 times per day using Visual analog scales until study completion. Average daily pain was calculated for each patient. Higher values portend worse control.

Conditions Studied

Interventions

  • DRUG Acetaminophen
  • DRUG Ketorolac
  • DRUG Celecoxib
  • DRUG Gabapentin
  • DRUG Hydrocodone-Acetaminophen

Study Locations (1)

Michigan

  • Henry Ford Health System - Detroit

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2019-01-22
Est. Completion 2020-05-20
Phase Phase 2
Henry Ford Health System

234 total trials

What NCT03825809 shows while recruiting

NCT03825809 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 101-participant average among 3 other Narcotic Use trials with a reported enrollment target.

The record links to 1 condition, with Narcotic Use appearing as the primary indexed condition, and to 5 interventions - of which Acetaminophen is the first listed.

NCT03825809 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT03825809 about?

NCT03825809 is a clinical study titled "Nonopioid Analgesia After Labral Surgery". This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given sta...

What is the current status of trial NCT03825809?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2019-01-22. Estimated completion is 2020-05-20.

What conditions does trial NCT03825809 study?

This clinical trial studies the following conditions: Narcotic Use.

What interventions are being tested in trial NCT03825809?

The interventions under investigation include: Acetaminophen (DRUG), Ketorolac (DRUG), Celecoxib (DRUG), Gabapentin (DRUG), Hydrocodone-Acetaminophen (DRUG).

Who is sponsoring clinical trial NCT03825809?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03825809 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Narcotic Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03825809, the US trial registry maintained by the National Library of Medicine. NCT03825809 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.